{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:34:34Z","timestamp":1759937674748,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006401","name":"Fondation Charcot","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3252-4","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:07:28Z","timestamp":1552565248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentan"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7387-9018","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Hostenbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayla","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Raeymaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Van Binst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Van Merhaeghen-Wieleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Van Schuerbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"De Keyser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"D\u2019Haeseleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"issue":"4 Suppl 2","key":"3252_CR1","doi-asserted-by":"publisher","first-page":"S825","DOI":"10.1007\/s100720070020","volume":"21","author":"M Liguori","year":"2000","unstructured":"Liguori M, Marrosu MG, Pugliatti M, Giuliani F, De Robertis F, Cocco E, et al. Age at onset in multiple sclerosis. Neurol Sci. 2000;21(4 Suppl 2):S825\u20139.","journal-title":"Neurol Sci"},{"issue":"3","key":"3252_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/jcbfm.2011.193","volume":"32","author":"M Cambron","year":"2012","unstructured":"Cambron M, D'Haeseleer M, Laureys G, Clinckers R, Debruyne J, De Keyser J. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J Cereb Blood Flow Metab. 2012;32(3):413\u201324.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"3252_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J","volume":"47","author":"N Evangelou","year":"2000","unstructured":"Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol. 2000;47(3):391\u20135.","journal-title":"Ann Neurol"},{"issue":"20","key":"3252_CR4","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1212\/WNL.0b013e3181c1e44f","volume":"73","author":"H Tremlett","year":"2009","unstructured":"Tremlett H, Yousefi M, Devonshire V, Rieckmann P, Zhao Y, Neurologists U. Impact of multiple sclerosis relapses on progression diminishes with time. Neurology. 2009;73(20):1616\u201323.","journal-title":"Neurology"},{"issue":"14","key":"3252_CR5","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1073\/pnas.1222560110","volume":"110","author":"M D'haeseleer","year":"2013","unstructured":"D'haeseleer M, Beelen R, Fierens Y, Cambron M, Vanbinst AM, Verborgh C, et al. Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc Natl Acad Sci U S A. 2013;110(14):5654\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3252_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S1474-4422(09)70043-2","volume":"8","author":"BD Trapp","year":"2009","unstructured":"Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009;8(3):280\u201391.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3252_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","volume":"81","author":"JR Moffett","year":"2007","unstructured":"Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 2007;81(2):89\u2013131.","journal-title":"Prog Neurobiol"},{"issue":"10","key":"3252_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1177\/1352458513477228","volume":"19","author":"C Steen","year":"2013","unstructured":"Steen C, D'haeseleer M, Hoogduin JM, Fierens Y, Cambron M, Mostert JP, et al. Cerebral white matter blood flow and energy metabolism in multiple sclerosis. Mult Scler. 2013;19(10):1282\u20139.","journal-title":"Mult Scler"},{"issue":"3","key":"3252_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1148\/radiol.2313030996","volume":"231","author":"M Law","year":"2004","unstructured":"Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology. 2004;231(3):645\u201352.","journal-title":"Radiology"},{"issue":"4","key":"3252_CR10","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.neuroimage.2006.08.008","volume":"33","author":"S Adhya","year":"2006","unstructured":"Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS, Grossman RI, et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage. 2006;33(4):1029\u201335.","journal-title":"Neuroimage"},{"issue":"1\u20132","key":"3252_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2008.12.036","volume":"282","author":"AW Varga","year":"2009","unstructured":"Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci. 2009;282(1\u20132):28\u201333.","journal-title":"J Neurol Sci"},{"issue":"6","key":"3252_CR12","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1002\/mrm.24194","volume":"68","author":"EZ Papadaki","year":"2012","unstructured":"Papadaki EZ, Mastorodemos VC, Amanakis EZ, Tsekouras KC, Papadakis AE, Tsavalas ND, et al. White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome. Magn Reson Med. 2012;68(6):1932\u201342.","journal-title":"Magn Reson Med"},{"issue":"7","key":"3252_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/BF03033159","volume":"5","author":"G Aliev","year":"2003","unstructured":"Aliev G, Smith MA, Obrenovich ME, de la Torre JC, Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox Res. 2003;5(7):491\u2013504.","journal-title":"Neurotox Res"},{"issue":"9","key":"3252_CR14","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/jcbfm.2015.131","volume":"35","author":"M D'haeseleer","year":"2015","unstructured":"D'haeseleer M, Hostenbach S, Peeters I, Sankari SE, Nagels G, De Keyser J, et al. Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis? J Cereb Blood Flow Metab. 2015;35(9):1406\u201310.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"3252_CR15","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","volume":"7","author":"ND Chiaravalloti","year":"2008","unstructured":"Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7(12):1139\u201351.","journal-title":"Lancet Neurol"},{"issue":"Pt 4","key":"3252_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/brain\/awn030","volume":"131","author":"NL Sicotte","year":"2008","unstructured":"Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, et al. Regional hippocampal atrophy in multiple sclerosis. Brain. 2008;131(Pt 4):1134\u201341.","journal-title":"Brain"},{"issue":"4\u20135","key":"3252_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.autrev.2014.01.012","volume":"13","author":"R Milo","year":"2014","unstructured":"Milo R, Miller A. Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev. 2014;13(4\u20135):518\u201324.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"3252_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444\u201352.","journal-title":"Neurology"},{"issue":"10","key":"3252_CR19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121\u20133.","journal-title":"Arch Neurol"},{"issue":"3","key":"3252_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/occmed\/kqv106","volume":"66","author":"E D\u2019Souza","year":"2016","unstructured":"D\u2019Souza E. Modified fatigue impact scale \u2013 5-item version (MFIS-5). Occup Med. 2016;66(3):256\u20137.","journal-title":"Occup Med"},{"issue":"2","key":"3252_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0022-3999(03)00371-4","volume":"56","author":"AJ Dittner","year":"2004","unstructured":"Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157\u201370.","journal-title":"J Psychosom Res"},{"issue":"4","key":"3252_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1590\/1516-4446-2012-1048","volume":"35","author":"YP Wang","year":"2013","unstructured":"Wang YP, Gorenstein C. Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Rev Bras Psiquiatr. 2013;35(4):416\u201331.","journal-title":"Rev Bras Psiquiatr"},{"key":"3252_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12883-015-0460-8","volume":"15","author":"C Niccolai","year":"2015","unstructured":"Niccolai C, Portaccio E, Goretti B, Hakiki B, Giannini M, Past\u00f2 L, et al. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients. BMC Neurol. 2015;15:204.","journal-title":"BMC Neurol"},{"issue":"6","key":"3252_CR24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012;18(6):891\u20138.","journal-title":"Mult Scler"},{"key":"3252_CR25","unstructured":"Fischer JS, Jak AJ, Kniker JE, Rudick RA, Cutter G. Multiple Sclerosis functional composite (MSFC): administration and scoring manual: National Multiple Sclerosis Society; 2001. \n                    http:\/\/main.nationalmssociety.org\/docs\/HOM\/MSFC_Manual_and_Forms.pdf\n                    \n                  ."},{"key":"3252_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nbd.2017.04.007","volume":"104","author":"A Brureau","year":"2017","unstructured":"Brureau A, Blanchard-Bregeon V, Pech C, Hamon S, Chaillou P, Guillemot JC, et al. NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration. Neurobiol Dis. 2017;104:73\u201384.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"3252_CR27","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1177\/1352458515623365","volume":"22","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Disanto G, Mathias A, Soneson C, Bonnier G, et al. Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity. Mult Scler. 2016;22(12):1550\u20139.","journal-title":"Mult Scler"},{"issue":"4","key":"3252_CR28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1750-3639.2003.tb00485.x","volume":"13","author":"U Graumann","year":"2003","unstructured":"Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 2003;13(4):554\u201373.","journal-title":"Brain Pathol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3252-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3252-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3252-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:49:22Z","timestamp":1584060562000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3252-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3252"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3252-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2019,3,14]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This trial will be conducted in accordance with Good Clinical Practice Guidelines and has been approved by the FAGG and by the Local Ethics Committee of the UZ Brussel (EudraCT 2017\u2013001253-13). Informed consent of all patients will be obtained before the enrolment in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"164"}}